1-2 of 2
James H Garvin, Jr., MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduced-Toxicity (RTC) Versus Myeloablative Conditioning (MAC) Prior to Allogeneic Stem Cell Transplantation in Pediatric Participants: Significant Improvement in Physical Functioning Following RTC Versus MAC

Jennifer A Oberg, EdD, Erin Morris, RN, Lauren Harrison, RN, MSN, Julia Glade Bender, MD, James H Garvin, Jr., MD, PhD, Stephen Sands, PsyD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2011) 118 (21): 2069.
https://doi.org/10.1182/blood.V118.21.2069.2069
Published: 2011
Journal Articles

A Pilot Study of Reduced Toxicity Conditioning (RTC) with Busulfan (Bu), Fludarabine (Flu), and Alemtuzumab Followed by Allogeneic Stem Cell Transplantation (AlloSCT) to Induce Sustained Mixed Donor Chimerism In Patients with Symptomatic Sickle Cell Disease (SCD)

Monica Bhatia, MD, Mark B Geyer, AB, Courtney Baker, RN, MSN, PNP, Erin Morris, RN, BSN, Deirdre Duffy, BS, Diane George, MD, James H Garvin, Jr., MD, PhD, Prakash Satwani, MD, Joseph Schwartz, MD, Sandra Foley, CPNP, Ria Hawks, CPNP, Elana Hamburger-Smilow, CPNP, Lee Ann Baxter-Lowe, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2010) 116 (21): 3504.
https://doi.org/10.1182/blood.V116.21.3504.3504
Published: 2010